375 related articles for article (PubMed ID: 16798570)
21. Methods for clinical assessment of expectorants: a critical review.
Lurie A; Mestiri M; Huchon G; Marsac J; Lockhart A; Strauch G; Bergogne-Berezin E; Bignon J; Carbon C; Chwalow J
Int J Clin Pharmacol Res; 1992; 12(1):47-52. PubMed ID: 1526698
[TBL] [Abstract][Full Text] [Related]
22. Mucus and mucins.
Rubin BK
Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review.
Sathe NA; Krishnaswami S; Andrews J; Ficzere C; McPheeters ML
Respir Care; 2015 Jul; 60(7):1061-70. PubMed ID: 25944943
[TBL] [Abstract][Full Text] [Related]
24. Rationale of airway clearance.
Clarke SW
Eur Respir J Suppl; 1989 Jul; 7():599s-603s. PubMed ID: 2679608
[TBL] [Abstract][Full Text] [Related]
25. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
Ertogan F
Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
[No Abstract] [Full Text] [Related]
26. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
27. Management of mucus hypersecretion.
Clarke SW
Eur J Respir Dis Suppl; 1987; 153():136-44. PubMed ID: 3322858
[TBL] [Abstract][Full Text] [Related]
28. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
[TBL] [Abstract][Full Text] [Related]
29. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
[TBL] [Abstract][Full Text] [Related]
30. Respiratory-related quality of life: relation to pulmonary function, functional exercise capacity, and sputum biophysical properties.
Piquette CA; Clarkson L; Okamoto K; Kim JS; Rubin BK
J Aerosol Med; 2000; 13(3):263-72. PubMed ID: 11066029
[TBL] [Abstract][Full Text] [Related]
31. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
Dorow P; Weiss T; Felix R; Köhler M
Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
[TBL] [Abstract][Full Text] [Related]
32. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
33. Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.
Yan X; Song Y; Shen C; Xu W; Chen L; Zhang J; Liu H; Huang M; Lai G; Qian G; Wang J; Ye X; Zheng J; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():803-812. PubMed ID: 28405161
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
35. Physiology of airway mucus clearance.
Rubin BK
Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic activity of an association of a mucolytic drug and a bronchodilator agent in the treatment of respiratory inflammations].
Boselli G
Minerva Med; 1973 Nov; 64(79):4128-37. PubMed ID: 4765427
[No Abstract] [Full Text] [Related]
37. [Mucociliary clearance function and medicamentous modification].
Konrad F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Sep; 31(7):404-8. PubMed ID: 8991466
[TBL] [Abstract][Full Text] [Related]
38. Effect of inhaled dry powder mannitol on mucus and its clearance.
Daviskas E; Rubin BK
Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
[TBL] [Abstract][Full Text] [Related]
39. The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Sun L; Tang L; Xu Y; Wang S; Li Y; Kang J
Respirology; 2010 Oct; 15(7):1064-71. PubMed ID: 20807377
[TBL] [Abstract][Full Text] [Related]
40. Managing secretions in dying patients.
Sorenson HM
Respir Care; 2000 Nov; 45(11):1355-63; discussion 1363-4. PubMed ID: 11063523
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
